NEW YORK (GenomeWeb) – OpGen reported after the close of the market on Tuesday that its third quarter revenues fell 2 percent year over year.

For the three months ended Sept. 30, the firm reported total revenues of $745,144, down from $759,663 in Q3 2016. Product sales fell to $729,742 from $730,325 in the year-ago quarter, while lab services revenues fell to $9,070 from $23,036, and collaboration revenues remained flat at $6,302.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.